Priya Singhal
Corporate Officer/Principal at BIOGEN INC.
Net worth: 989 220 $ as of 2024-04-29
Priya Singhal active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2023-10-01 | - |
| Chief Tech/Sci/R&D Officer | 2021-12-30 | 2023-10-01 |
Career history of Priya Singhal
Former positions of Priya Singhal
| Companies | Position | Start | End |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 2007-12-31 | 2011-12-31 |
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-03-03 | - |
Training of Priya Singhal
| Harvard T.H. Chan School of Public Health | Graduate Degree |
| University of Mumbai | Doctorate Degree |
Statistics
International
| United States | 5 |
| India | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Private companies | 1 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Priya Singhal
- Experience
